Cargando…

Immuno-metabolic dendritic cell vaccine signatures associate with overall survival in vaccinated melanoma patients

Efficacy of cancer vaccines remains low and mechanistic understanding of antigen presenting cell function in cancer may improve vaccine design and outcomes. Here, we analyze the transcriptomic and immune-metabolic profiles of Dendritic Cells (DCs) from 35 subjects enrolled in a trial of DC vaccines...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adamik, Juraj, Munson, Paul V., Maurer, Deena M., Hartmann, Felix J., Bendall, Sean C., Argüello, Rafael J., Butterfield, Lisa H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632482/ https://www.ncbi.nlm.nih.gov/pubmed/37938561 http://dx.doi.org/10.1038/s41467-023-42881-4

Ejemplares similares

Distinct metabolic states guide maturation of inflammatory and tolerogenic dendritic cells
por: Adamik, Juraj, et al.
Publicado: (2022)

Polyunsaturated Fatty Acid–Bound α-Fetoprotein Promotes Immune Suppression by Altering Human Dendritic Cell Metabolism
por: Munson, Paul V., et al.
Publicado: (2023)

Cellular immunity induced by a recombinant adenovirus- human dendritic cell vaccine for melanoma
por: Naveh, Hadas Prag, et al.
Publicado: (2013)

Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients
por: Ridolfi, Ruggero, et al.
Publicado: (2006)

Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanoma
por: Storkus, Walter J, et al.
Publicado: (2021)

Impact of checkpoint blockade on cancer vaccine–activated CD8(+) T cell responses
por: Santos, Patricia M., et al.
Publicado: (2020)

Multiple antigen-engineered DC vaccines with or without IFNα to promote antitumor immunity in melanoma
por: Butterfield, Lisa H., et al.
Publicado: (2019)

CD8+ T cell responses in metastatic melanoma patients receiving an adenovirally antigen engineered dendritic cell vaccine +/- IFN-α
por: Du, Samuel, et al.
Publicado: (2015)

Activation of tonsil dendritic cells with immuno-adjuvants
por: Polak, Marta E, et al.
Publicado: (2008)

Prolonged repeated vaccine immuno-chemotherapy induces long-term clinical responses and survival for advanced metastatic melanoma
por: Coventry, Brendon J, et al.
Publicado: (2014)

Adjuvant dendritic cell vaccination in high-risk uveal melanoma patients
por: Bol, Kalijn, et al.
Publicado: (2015)

Identification of Prognostic Signatures for Predicting the Overall Survival of Uveal Melanoma Patients
por: Xue, Meijuan, et al.
Publicado: (2019)

Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients
por: Bol, Kalijn F, et al.
Publicado: (2015)

Stability Program in Dendritic Cell Vaccines: A “Real-World” Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center
por: Pancisi, Elena, et al.
Publicado: (2022)

Dendritic Cell-Based Vaccines Positively Impact Natural Killer and Regulatory T Cells in Hepatocellular Carcinoma Patients
por: Bray, Sarah M., et al.
Publicado: (2011)

Ipilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccination
por: Boudewijns, Steve, et al.
Publicado: (2016)

Cancer vaccines as promising immuno-therapeutics: platforms and current progress
por: Liu, Jian, et al.
Publicado: (2022)

Live Attenuated S. Typhimurium Vaccine with Improved Safety in Immuno-Compromised Mice
por: Periaswamy, Balamurugan, et al.
Publicado: (2012)

Interleukin 32 expression in human melanoma
por: Paz, Helicia, et al.
Publicado: (2019)

Cancer vaccines
por: Butterfield, Lisa H
Publicado: (2015)

ASO Author Reflections: The Tumor Lysate, Particle-Loaded, Dendritic Cell Vaccine for Advanced-Stage Melanoma: Reflection on Personalized Cancer Vaccination
por: Adams, Alexandra M., et al.
Publicado: (2021)

Efficiency of Dendritic Cell Vaccination against B16 Melanoma Depends on the Immunization Route
por: Edele, Fanny, et al.
Publicado: (2014)

Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma
por: Markov, Oleg V., et al.
Publicado: (2015)

Dendritic cell-based vaccination in metastatic melanoma patients: Phase II clinical trial
por: OSHITA, CHIE, et al.
Publicado: (2012)

Immuno-oncology approaches in uveal melanoma: tebentafusp and beyond
por: Gerard, C., et al.
Publicado: (2023)

Immune signature as predictive marker for response to checkpoint inhibitor immunotherapy and overall survival in melanoma
por: Krebs, Franziska K., et al.
Publicado: (2021)

Melanoma vaccines.
Publicado: (1998)

The Search of a Malaria Vaccine: The Time for Modified Immuno-Potentiating Probes
por: Lozano, José Manuel, et al.
Publicado: (2021)

The impact of immuno-aging on SARS-CoV-2 vaccine development
por: Connors, Jennifer, et al.
Publicado: (2021)

A Universal Live Cell Barcoding-Platform for Multiplexed Human Single Cell Analysis
por: Hartmann, Felix J., et al.
Publicado: (2018)

Dendritic cell vaccination and immune monitoring
por: Aarntzen, E. H. J. G., et al.
Publicado: (2008)

Estimating Lifetime Benefits Associated with Immuno-Oncology Therapies: Challenges and Approaches for Overall Survival Extrapolations
por: Ouwens, Mario J. N. M., et al.
Publicado: (2019)

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
por: Li, Qiao, et al.
Publicado: (2014)

Patient-specific dendritic cell vaccines with autologous tumor antigens in 72 patients with metastatic melanoma
por: Dillman, Robert O, et al.
Publicado: (2019)

Dendritic Cell Vaccination in Metastatic Melanoma Turns “Non-T Cell Inflamed” Into “T-Cell Inflamed” Tumors
por: Bulgarelli, Jenny, et al.
Publicado: (2019)

From Melanoma Development to RNA-Modified Dendritic Cell Vaccines: Highlighting the Lessons From the Past
por: Shadbad, Mahdi Abdoli, et al.
Publicado: (2021)

Interleukin-2 Production by Dendritic Cells and its Immuno-Regulatory Functions
por: Zelante, Teresa, et al.
Publicado: (2012)

Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma
por: Pardee, Angela D., et al.
Publicado: (2015)

Single-cell motility and gene expression signature as predictors of the overall survival of act in melanoma patients
por: Martinez-Paniagua, Melisa, et al.
Publicado: (2015)

Dendritic Cell-Targeted Vaccines
por: Cohn, Lillian, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ii7i2n3d20s62onu9ckl9mhg1c